Nasdaq
PASG
Passage Bio, Inc.
- Health Care
- Listed 2020
- 1 day
- −4.6%
- 1 month
- −12.0%
- 1 year
- −22.2%
$4.40 · Mkt cap $14.1M
At the 6 Aug 2026 close
Nasdaq
Passage Bio, Inc.
$4.40 · Mkt cap $14.1M
At the 6 Aug 2026 close
Passage Bio, Inc. trades under the ticker PASG on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $14.1M. The last closing price was $4.40, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −22.2%, and −12.0% over the past month. Returns are price returns and exclude dividends.
This page exists because PASG is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.